Decoy Therapeutics Regains Nasdaq Compliance

Decoy Therapeutics, Inc. (Nasdaq: DCOY) has regained compliance with Nasdaq's Listing Rule 5550(a)(2), which pertains to the Minimum Bid Price Requirement, as of March 31, 2026. The company is now in compliance with all other applicable continued listing requirements of The Nasdaq Capital Market.